Pricing Log in Create free account

Gyre Therapeutics, Inc. (GYRE) vs PureTech Health PLC Sponsored ADR (PRTCY)

Gyre Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. Gyre Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are of similar size ($425.2M and $424.0M). PureTech Health PLC Sponsored ADR grew revenue faster over the last twelve months: 28.5% against 13.5%. Gyre Therapeutics, Inc. has the higher net margin (−21.5% vs −199.4%) and the lower return on invested capital (−8.51% vs 0.00%). Across the 14 metrics below, PureTech Health PLC Sponsored ADR leads on 9 and Gyre Therapeutics, Inc. on 5.

Valuation

Metric GYRE PRTCY Biotechnology median
P/E n/m n/m 10.60
P/S 4.12 n/m 9.40
P/B 3.47 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.81 0.66
EV/Sales 3.55 (9.10) 9.02
Earnings yield (5.93%) (1.32%) (32.88%)
Free cash flow yield (5.07%) 0.00% (23.13%)

Profitability

Metric GYRE PRTCY Biotechnology median
Gross margin 91.71% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (21.46%) (199.36%) 0.00%
Free cash flow margin (19.94%) 0.00% 0.00%
Return on equity (18.54%) 0.00% (51.96%)
Return on assets (14.49%) 0.00% (46.06%)
Return on invested capital (8.51%) 0.00% 0.00%

Growth

Metric GYRE PRTCY Biotechnology median
Revenue growth (TTM) 13.51% 28.48% 6.76%
EPS growth (last fiscal year) (60.00%) (318.75%) 29.88%
Revenue growth, 5-year CAGR 40.96% (16.92%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GYRE PRTCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.32 6.59 4.97
Net debt to EBITDA (3.74) 3.03 1.01

Dividend

Metric GYRE PRTCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GYRE PRTCY Biotechnology median
Market cap 425.20m 424.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack